NCT07226453
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07226453
Title Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma (PNOC041)
Acronym PNOC041
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham RECRUITING Birmingham Alabama 35233 United States Details
University of California, San Francisco RECRUITING San Francisco California 94143 United States Details
Children's National Medical Center NOT_YET_RECRUITING Washington D.C. District of Columbia 20010 United States Details
Johns Hopkins University RECRUITING Baltimore Maryland 21287 United States Details
University of Michigan NOT_YET_RECRUITING Ann Arbor Michigan 48109 United States Details
Washington University RECRUITING St Louis Missouri 63110 United States Details
Hackensack Meridian Health NOT_YET_RECRUITING Hackensack New Jersey 07601 United States Details
Duke University RECRUITING Durham North Carolina 27710 United States Details
St. Jude Children's Research Hospital NOT_YET_RECRUITING Memphis Tennessee 38105 United States Details
University of Utah RECRUITING Salt Lake City Utah 84113 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field